Reply to the Editor:  by Beaver, Thomas M. et al.
RIFLE criteria in aortic arch
surgery: The further role of
surgical subgroup
To the Editor:
I read with great interest the recent article by
Arnaoutakis and colleagues1 detailing their
application of the RIFLE (risk, injury, fail-
ure, loss, end stage) criteria in aortic arch sur-
gery. Arnaoutakis and colleagues1 clearly
demonstrated a significant relationship be-
tween degree of renal injury and operative
mortality. Their series of 267 patients, how-
ever, was heterogeneous with respect to aor-
tic pathology: 35.6% of the cases (95/267)
were aortic dissection, with 74.7% (71/95)
being acute and necessitating emergency
surgery with deep hypothermic circulatory
arrest.
The clinical presentation of acute aortic
dissection significantly determines operative
risk and mortality, particularly when it is
associated with organ ischemia.2 Thus this
confounding effect of an aortic arch subgroup
with distinctive presentations ideally merits
a de novo analysis in a large acute aortic dis-
section series. This goal would require many
years to achieve for a single center, however,
even a single, high-volume experienced cen-
ter. As a result, current single-center series,
including our own,3 have included acute aor-
tic dissection as a subgroup and thus been un-
able to escape the confounding effects of the
mixed aortic arch cohort.3 I look forward to
future multicenter trials with adequate power
to examine the RIFLE criteria in aortic arch
surgical cohorts stratifiedbyaortic pathology.
I congratulate Arnaoutakis and col-
leagues1 again on their important contribu-
tion. I look forward to their comments
about this aspect of trial design.
John G. T. Augoustides, MD, FASE
Assistant Professor, Department of
Anesthesiology and Critical Care
Hospital of the University of Pennsylvania
Philadelphia, PA 19104
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Reply to the Editor:
I thank Dr Pocar for promoting a discussion
about our article and technical proposition.
In fact, the juxtaposition of the right free
wall over the septum is not new and was ap-
plied for the first time by Boer and Boer in
1998;1 they called it ‘‘septal stabilization.’’
The authors2,3 cited by Dr Pocar made an
intelligent association of 2 techniques, that
is, septal stabilization1 and infarction exclu-
sion,4 with good results.
In our study, we proposed the juxtaposi-
tion of both the right and left free walls over
the septum, and this is the originality of the
Letters to the EditorReply to the Editor:
We appreciate the interest of Dr Augousti-
des in our article,1 and he raises a valid point
that the subgroup of patients with acute
aortic dissection are at even higher risk
for acute kidney injury because of their
emergency presentation and variable mal-
perfusion. Patients with acute dissection
accounted for 71 of the 97 emergency oper-
ations in our series. In the multivariate anal-
ysis, emergency surgery (and accordingly
acute dissection) was not identified as
a risk factor for either acute kidney injury
or mortality. As Dr Augoustides noted,
however, it would require many years for
a single center to examine this question.
The RIFLE criteria provide standardized
outcome definitions to study acute kidney
injury in patients undergoing arch aortic sur-
gery—a group known to be at significant
risk for renal injury. Standardized defini-
tions are the first step if we are to compare
outcomes at aortic centers interested in acute
kidney injury.
To take the next step—examination of
renal protective strategies—we concur
with Dr Augoustides that patients should
be stratified according to aortic pathology
and also that it will take the cooperation of
several centers with large aortic experi-
ences. The question then arises, which pro-
tective strategies could we study? We and
others have been intrigued by the potentially
favorable renal effects of nesiritide (Natre-
cor; Scios Inc, Fremont, Calif).2-5*
It is important to note that even less
severe kidney injury after cardiac surgery
has been found to be independently asso-
ciated with in-hospital and long-term mor-
tality.6,7 Accordingly, with interest from
the center of Dr Augoustides, our own,
and others, perhaps it is now time to ask
the National Institutes of Health to support
a randomized, multicenter trial adequately
powered to determine whether nesiritide
(or other potential agents) can afford
high-risk patients undergoing thoracic aor-
tic surgery protection against acute kidney
injury.The Journal of Thoracic and CardiovascuThomas M. Beaver, MD, MPH
Azra Bihorac, MD
Ahsan A. Ejaz, MD
Division of Cardiovascular Surgery
University of Florida
Gainesville, FL 32610
*Disclosure: Authors have received research sup-
port from Scios Inc.
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